stage iii breast cancer

Showing 1 - 25 of 35

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

ctDNA During Neoadjuvant Chemotherapy for Breast Cancer.

Recruiting
  • Breast Cancer Female
  • +4 more
    • Ho Chi Minh City, Vietnam
    • +1 more
    Oct 16, 2023

    Estrogen Receptor Negative, HER2/Neu Negative, Invasive Breast Carcinoma Trial in South Africa, United States (drug, other,

    Active, not recruiting
    • Estrogen Receptor Negative
    • +11 more
    • Mobile, Alabama
    • +1023 more
    Dec 7, 2022

    Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in Bellevue, Grand Island, Omaha (drug, other,

    Active, not recruiting
    • Estrogen Receptor Negative
    • +15 more
    • Bellevue, Nebraska
    • +3 more
    Nov 30, 2022

    HER2 Positive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer Trial in Palo Alto (Utomilumab, Trastuzumab,

    Completed
    • HER2 Positive Breast Carcinoma
    • +6 more
    • Palo Alto, California
      Stanford University, School of Medicine
    Sep 22, 2022

    Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)

    Terminated
    • Estrogen Receptor Positive
    • +16 more
    • Biopsy of Breast
    • +5 more
    • Los Angeles, California
      UCLA / Jonsson Comprehensive Cancer Center
    Sep 22, 2022

    Early-stage Breast Cancer, Hormone Receptor Positive Breast Carcinoma, Invasive Breast Cancer Trial in United States (drug,

    Recruiting
    • Early-stage Breast Cancer
    • +6 more
    • Fullerton, California
    • +8 more
    Sep 19, 2022

    Breast Cancer, Stage III Breast Cancer, Breast Cancer Female Trial in Boston (THRIVE, Health Education Support Program)

    Not yet recruiting
    • Breast Cancer
    • +4 more
    • THRIVE
    • Health Education Support Program
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Sep 8, 2022

    Breast Cancer, Prostate Cancer, Colorectal Cancer Trial in United States (Exercise)

    Recruiting
    • Breast Cancer
    • +11 more
    • Exercise
    • San Carlos, California
    • +7 more
    Aug 24, 2022

    Breast Cancer, Breast Cancer Female, Breast Cancer, Male Trial in Tampa (biological, drug, procedure)

    Recruiting
    • Breast Cancer
    • +7 more
    • Dendritic Cell Vaccine (DC1)
    • +2 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Aug 23, 2022

    ER-positive Breast Cancer, HER2-negative Breast Cancer, Stage IIB Breast Cancer Trial (Elacestrant, Tamoxifen, Letrozole 2.5mg)

    Not yet recruiting
    • ER-positive Breast Cancer
    • +3 more
    • (no location specified)
    Aug 22, 2022

    Defining Clinical Potential of Mass Response asBiomarker for

    Recruiting
    • Stage III Breast Cancer
    • +5 more
      • Columbus, Georgia
        Columbus Regional Research Institute, John B. Amos Cancer Center
      Jul 13, 2022

      HER-2 Positive Breast Cancer, Breast Cancer, Stage II Breast Cancer Trial in Boston, Nashville (T-DM1, Pertuzumab, Excision of

      Active, not recruiting
      • HER-2 Positive Breast Cancer
      • +3 more
      • Boston, Massachusetts
      • +3 more
      Mar 4, 2022

      Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer Trial in Aurora (Exemestane, Exemestane and tamoxifen)

      Completed
      • Breast Cancer
      • +2 more
      • Aurora, Colorado
        University of Colorado Cancer Center
      Feb 22, 2022

      HER2 Negative Breast Carcinoma, Recurrent Breast Carcinoma, Stage IIIA Breast Cancer Trial in Seattle

      Recruiting
      • HER2 Negative Breast Carcinoma
      • +6 more
      • CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
      • Laboratory Biomarker Analysis
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Feb 18, 2022

      HER2/Neu Negative, No Evidence of Disease, One or More Positive Axillary Nodes Trial in Seattle, Madison (Laboratory Biomarker

      Active, not recruiting
      • HER2/Neu Negative
      • +10 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Seattle, Washington
      • +1 more
      Jan 11, 2022

      Breast Cancer Female, Stage I Breast Cancer, Stage II Breast Cancer Trial in Austin (Breast reconstruction decision aid,

      Completed
      • Breast Cancer Female
      • +6 more
      • Breast reconstruction decision aid
      • Educational website
      • Austin, Texas
        Texas Oncology
      Nov 1, 2021

      Stage II Breast Cancer, Stage III Breast Cancer, Stage IV Breast Cancer Trial in United States (Behavioral Intervention)

      Recruiting
      • Stage II Breast Cancer
      • +22 more
      • Behavioral Intervention
      • Bay City, Michigan
      • +7 more
      Sep 29, 2021

      Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer Trial in Nashville (Atezolizumab, Cobimetinib,

      Terminated
      • Stage III Breast Cancer
      • +6 more
      • Nashville, Tennessee
        Vanderbilt-Ingram Cancer Center
      Aug 10, 2021

      Taxane-induced Peripheral Neuropathy, Chemo-induced Peripheral Neuropathy (CIPN), Early-Stage Breast Carcinoma Trial in Boston

      Completed
      • Taxane-induced Peripheral Neuropathy
      • +5 more
      • Immediate Acupuncture Group
      • Delayed Acupuncture Group
      • Boston, Massachusetts
        Dana Farber Cancer Institute
      Jul 26, 2021

      Primary Invasive Malignant Tumor of Female Breast, Carcinoma Breast, Breast Cancer Female Trial in United States

      Completed
      • Primary Invasive Malignant Neoplasm of Female Breast
      • +6 more
      • Investigational Imaging device
      • AVB-620
      • San Diego, California
      • +12 more
      Jun 10, 2021

      Malignant Female Reproductive System Tumor, Malignant Hepatobiliary Tumor, Partner Trial in New Brunswick (Cognitive Behavior

      Completed
      • Malignant Female Reproductive System Neoplasm
      • +38 more
      • Cognitive Behavior Therapy
      • +3 more
      • New Brunswick, New Jersey
        Rutgers Cancer Institute of New Jersey
      Apr 7, 2021

      Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in Chicago, Lake Forest (drug, other,

      Unknown status
      • Estrogen Receptor Negative
      • +9 more
      • Chicago, Illinois
      • +1 more
      Jun 25, 2020

      Peripheral Neuropathy, Stage 0 Breast Cancer, Stage I Breast Cancer Trial in Winston-Salem (procedure, other, diagnostic test)

      Completed
      • Peripheral Neuropathy
      • +12 more
      • Biopsy
      • +2 more
      • Winston-Salem, North Carolina
        Comprehensive Cancer Center of Wake Forest University
      May 8, 2020